+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Inflammatory Bowel Disease Treatment Market Size, Share & Trends Analysis Report By Type (Crohn's Disease, Ulcerative Colitis), By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2023
  • Region: Global
  • Grand View Research
  • ID: 5457623

Quick Summary:

In the ever-expanding sphere of healthcare, the global inflammatory bowel disease treatment market is set for significant progression. Attributing to increasing prevalence of diseases like Crohn’s and Ulcerative Colitis, surging awareness about inflammatory bowel disease, and favorable regulatory scenarios, the said market is anticipated to undergo notable growth. Government bodies and regulatory authorities continue to sanction initiatives and approve novel treatments, providing impetus to develop new therapeutic approaches.

Progress in the field of biosimilars and increased collaborative activities between major market players, non-profit organizations and regulatory authorities are providing new avenues for advancements in Inflammatory Bowel Disease treatments. The recent approvals of novel drugs and promising research cater for a robust pipeline of therapeutics that promise to address the unmet needs in the IBD treatment market. The emphasis on research and development of novel therapeutic products signals a promising, expanding market opportunity for potential investors and stakeholders within the healthcare field.

The global inflammatory bowel disease treatment market size is expected to reach USD 27.0 billion, expanding at a CAGR of 3.6% from 2023 to 2030. The increasing prevalence of the disease, the surge in awareness about inflammatory bowel disease among people, and favorable regulatory scenarios are projected to drive the inflammatory bowel disease treatment market over the forecast period. For instance, in December 2022, Pfizer Inc. announced the U.S. FDA acceptance for review of an NDA for etrasimod for patients having severe ulcerative colitis. The favorable initiatives undertaken by regulatory authorities for treatment designations and approval of novel drugs for the management of inflammatory bowel disease are fueling market expansion.

The increasing collaboration of market players and non-profit organizations to counter various challenges in the development of novel therapeutics for IBD treatment is projected to propel market growth. For instance, in October 2022, Verily, a precision health company and the Crohn’s & Colitis Foundation expanded their strategic collaboration to accelerate research in ulcerative colitis and Crohn’s disease. In addition, the European Crohn’s and Colitis Organization has taken several favorable steps to improve the care of patients living with inflammatory bowel disease.

Recently approved novel drugs such as filgotinib, ozanimod, upadacitinib, and risankizumab for the treatment of inflammatory bowel disease are expected to support market growth in the coming years. Moreover, the regulatory authorities are encouraging manufacturers to develop novel therapeutic approaches for rare and life-threatening diseases. For instance, in December 2020, Thetis Pharmaceuticals received an orphan drug designation for TP-317 from the U.S. FDA for pediatric ulcerative colitis. Such favorable initiatives are expected to boost the R&D activities to develop novel therapeutic products for IBD.

Furthermore, the rising demand & approvals for biosimilars for the treatment of various inflammatory conditions is a high-impact rendering factor for the market. For instance, in December 2022, the U.S. FDA approved Idacio as an eighth adalimumab biosimilar in the U.S. The newly approved biosimilar is a citrate-free low-concentration preparation intended for the treatment of several inflammatory conditions, including CD in adults and children aged 6 years or older. In addition, in October 2021, the U.S. FDA approved Cyltezo for the management of moderate to severe CD and UC. Moreover, the increasing introduction of biosimilars is expected to boost the adoption of biological products for the treatment of IBD in developing economies.

Moreover, government bodies are taking efforts to promote the uptake of biosimilars with their safe use. For instance, in October 2022, the government of Saskatchewan launched a biosimilar initiative to help its residents to access high-quality therapeutics at a lesser cost. Similarly, provinces like Ontario and Quebec in Canada are also expanding biosimilar initiatives to promote the uptake of biosimilar candidates.

Inflammatory Bowel Disease Market Report Highlights

  • The Crohn’s disease segment held the largest share owing to the increasing prevalence of the condition and the high prescription rate of biologics for the treatment of the disease
  • The ulcerative colitis segment is poised to register the fastest growth rate due to the rising approval of biologics for the treatment of ulcerative colitis and the high patient base
  • The TNF inhibitors segment accounted for the largest market share in 2022 owing to the high prescription rate for the treatment of IBD and rising consumer awareness about TNF inhibitors
  • Based on the route of administration, the injectable segment dominated the inflammatory bowel disease treatment market in 2022, whereas the oral segment is anticipated to be the fastest-growing segment
  • The hospital pharmacy segment was the largest in 2022, owing to higher hospitalization rates and favorable reimbursement coverage
  • Asia Pacific is expected to exhibit the fastest growth rate over the forecast period due to the rising investments by market players and increasing disease prevalence in the region


This product will be delivered within 1-3 business days.
Frequently Asked Questions about the Global Inflammatory Bowel Disease Treatment Market

What is the estimated value of the Global Inflammatory Bowel Disease Treatment Market?

The Global Inflammatory Bowel Disease Treatment Market was estimated to be valued at $20.33 Billion in 2022.

What is the growth rate of the Global Inflammatory Bowel Disease Treatment Market?

The growth rate of the Global Inflammatory Bowel Disease Treatment Market is 3.6%, with an estimated value of $27 Billion by 2030.

What is the forecasted size of the Global Inflammatory Bowel Disease Treatment Market?

The Global Inflammatory Bowel Disease Treatment Market is estimated to be worth $27 Billion by 2030.

Who are the key companies in the Global Inflammatory Bowel Disease Treatment Market?

Key companies in the Global Inflammatory Bowel Disease Treatment Market include AbbVie Inc, Biogen, Takeda Pharmaceutical Company Limited, Novartis AG, Pfizer Inc, Lilly, UCB S.A., Johnson & Johnson Services, Inc., CELLTRION INC and Merck & Co., Inc.

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights

Chapter 3 Inflammatory Bowel Disease Treatment Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Robust product pipeline
3.2.1.2 High prevalence of crohn’s disease and ulcerative colitis
3.2.1.3 Increasing geriatric population
3.2.2 Market restraint analysis
3.2.2.1 High number of patent expirations
3.2.2.2 High cost of treatment
3.3 Penetration & Growth Prospect Mapping
3.4 Gastrointestinal Therapeutics: Market Analysis Tools
3.4.1 Industry analysis- Porter’s
3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis

Chapter 4 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Type, 2018 - 2030 (USD Million)
4.1 Definition and Scope
4.2 Type Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Inflammatory Bowel Disease Treatment Market, by Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Crohn's Disease
4.5.1.1 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
4.5.2 Ulcerative Colitis
4.5.2.1 Ulcerative colitis market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Drug Class 2018 - 2030 (USD Million)
5.1 Definition and Scope
5.2 Drug Class Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Inflammatory Bowel Disease Treatment Market, by Drug Class, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Aminosalicylates
5.5.1.1 Aminosalicylates market estimates and forecast, 2018 - 2030 (USD Million)
5.5.2 Corticosteroids
5.5.2.1 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
5.5.3 TNF inhibitors
5.5.3.1 TNF inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
5.5.4 IL inhibitors
5.5.4.1 IL inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
5.5.5 Anti-integrin
5.5.5.1 Anti-integrin market estimates and forecast, 2018 - 2030 (USD Million)
5.5.6 JAK inhibitors
5.5.6.1 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
5.5.7 Others
5.5.7.1 Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Route of Administration, 2018 - 2030 (USD Million)
6.1 Definition and Scope
6.2 Route of Administration Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Inflammatory Bowel Disease Treatment Market, by Route of Administration, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Oral
6.5.1.1 Oral market estimates and forecast, 2018 - 2030 (USD Million)
6.5.2 Injectable
6.5.2.1 Injectable market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 7 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)
7.1 Definition and Scope
7.2 Distribution Channel Market Share Analysis, 2022 & 2030
7.3 Segment Dashboard
7.4 Global Inflammatory Bowel Disease Treatment Market, by Distribution Channel, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
7.5.1 Hospital Pharmacy
7.5.1.1 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.5.2 Retail Pharmacy
7.5.2.1 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
7.5.3 Online Pharmacy
7.5.3.1 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8 Inflammatory Bowel Disease Treatment Market Segment Analysis, By Region, 2018 - 2030 (USD Million)
8.1 Definition & Scope
8.2 Regional Market Share Analysis, 2022 & 2030
8.3 Regional Market Dashboard
8.4 Regional Market Snapshot
8.5 SWOT Analysis
8.5.1 North America
8.5.2 Europe
8.5.3 Asia Pacific
8.5.4 Latin America
8.5.5 Middle East and Africa
8.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
8.6.1 North America
8.6.1.1 North America inflammatory bowel disease treatment market , 2018 - 2030 (USD Million)
8.6.1.2 U.S.
8.6.1.2.1 Key Country Dynamics
8.6.1.2.2 Competitive Scenario
8.6.1.2.3 Regulatory Framework
8.6.1.2.4 Reimbursement Scenario
8.6.1.2.5 U.S. inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.1.3 Canada
8.6.1.3.1 Key Country Dynamics
8.6.1.3.2 Competitive Scenario
8.6.1.3.3 Regulatory Framework
8.6.1.3.4 Reimbursement Scenario
8.6.1.3.5 Canada inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2 Europe
8.6.2.1 Europe inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
8.6.2.2 UK
8.6.2.2.1 Key Country Dynamics
8.6.2.2.2 Competitive Scenario
8.6.2.2.3 Regulatory Framework
8.6.2.2.4 Reimbursement Scenario
8.6.2.2.5 UK inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.3 Germany
8.6.2.3.1 Key Country Dynamics
8.6.2.3.2 Competitive Scenario
8.6.2.3.3 Regulatory Framework
8.6.2.23.4 Reimbursement Scenario
8.6.2.3.5 Germany inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.4 Spain
8.6.2.4.1 Key Country Dynamics
8.6.2.4.2 Competitive Scenario
8.6.2.4.3 Regulatory Framework
8.6.2.4.4 Reimbursement Scenario
8.6.2.4.5 Spain inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.5 France
8.6.2.5.1 Key Country Dynamics
8.6.2.5.2 Competitive Scenario
8.6.2.5.3 Regulatory Framework
8.6.2.5.4 Reimbursement Scenario
8.6.2.5.5 France inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.6 Italy
8.6.2.6.1 Key Country Dynamics
8.6.2.6.2 Competitive Scenario
8.6.2.6.3 Regulatory Framework
8.6.2.6.4 Reimbursement Scenario
8.6.2.6.5 Italy inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.7 Denmark
8.6.2.7.1 Key Country Dynamics
8.6.2.7.2 Competitive Scenario
8.6.2.7.3 Regulatory Framework
8.6.2.7.4 Reimbursement Scenario
8.6.2.7.5 Denmark inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.8 Sweden
8.6.2.8.1 Key Country Dynamics
8.6.2.8.2 Competitive Scenario
8.6.2.8.3 Regulatory Framework
8.6.2.8.4 Reimbursement Scenario
8.6.2.8.5 Sweden inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.2.9 Norway
8.6.2.9.1 Key Country Dynamics
8.6.2.9.2 Competitive Scenario
8.6.2.9.3 Regulatory Framework
8.6.2.9.4 Reimbursement Scenario
8.6.2.9.5 Norway inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3 Asia Pacific
8.6.3.1 Asia Pacific inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
8.6.3.2 Japan
8.6.3.2.1 Key Country Dynamics
8.6.3.2.2 Competitive Scenario
8.6.3.2.3 Regulatory Framework
8.6.3.2.4 Reimbursement Scenario
8.6.3.2.5 Japan inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.3 China
8.6.3.3.1 Key Country Dynamics
8.6.3.3.2 Competitive Scenario
8.6.3.3.3 Regulatory Framework
8.6.3.3.4 Reimbursement Scenario
8.6.3.3.5 China inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.4 India
8.6.3.4.1 Key Country Dynamics
8.6.3.4.2 Competitive Scenario
8.6.3.4.3 Regulatory Framework
8.6.3.4.4 Reimbursement Scenario
8.6.3.4.5 India inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.5 South Korea
8.6.3.5.1 Key Country Dynamics
8.6.3.5.2 Competitive Scenario
8.6.3.5.3 Regulatory Framework
8.6.3.5.4 Reimbursement Scenario
8.6.3.25.5 South Korea inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.6 Australia
8.6.3.6.1 Key Country Dynamics
8.6.3.6.2 Competitive Scenario
8.6.3.6.3 Regulatory Framework
8.6.3.6.4 Reimbursement Scenario
8.6.3.6.5 Australia inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.7 Thailand
8.6.3.7.1 Key Country Dynamics
8.6.3.7.2 Competitive Scenario
8.6.3.7.3 Regulatory Framework
8.6.3.7.4 Reimbursement Scenario
8.6.3.7.5 Thailand inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.3.8 Singapore
8.6.3.8.1 Key Country Dynamics
8.6.3.8.2 Competitive Scenario
8.6.3.8.3 Regulatory Framework
8.6.3.8.4 Reimbursement Scenario
8.6.3.8.5 Thailand inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4 Latin America
8.6.4.1 Latin America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
8.6.4.2 Brazil
8.6.4.2.1 Key Country Dynamics
8.6.4.2.2 Competitive Scenario
8.6.4.2.3 Regulatory Framework
8.6.4.2.4 Reimbursement Scenario
8.6.4.2.5 Brazil inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4.3 Mexico
8.6.4.3.1 Key Country Dynamics
8.6.4.3.2 Competitive Scenario
8.6.4.3.3 Regulatory Framework
8.6.4.3.4 Reimbursement Scenario
8.6.4.3.5 Mexico inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.4.4 Argentina
8.6.4.4.1 Key Country Dynamics
8.6.4.4.2 Competitive Scenario
8.6.4.4.3 Regulatory Framework
8.6.4.4.4 Reimbursement Scenario
8.6.4.4.5 Argentina inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5 MEA
8.6.5.1 MEA inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
8.6.5.2 South Africa
8.6.5.2.1 Key Country Dynamics
8.6.5.2.2 Competitive Scenario
8.6.5.2.3 Regulatory Framework
8.6.5.2.4 Reimbursement Scenario
8.6.5.2.5 South Africa inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.3 Saudi Arabia
8.6.5.3.1 Key Country Dynamics
8.6.5.3.2 Competitive Scenario
8.6.5.3.3 Regulatory Framework
8.6.5.3.4 Reimbursement Scenario
8.6.5.3.5 Saudi Arabia inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.4 UAE
8.6.5.4.1 Key Country Dynamics
8.6.5.4.2 Competitive Scenario
8.6.5.4.3 Regulatory Framework
8.6.5.4.4 Reimbursement Scenario
8.6.5.4.5 UAE inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)
8.6.5.5 Kuwait
8.6.5.5.1 Key Country Dynamics
8.6.5.5.2 Competitive Scenario
8.6.5.5.3 Regulatory Framework
8.6.5.5.4 Reimbursement Scenario
8.6.5.5.5 Kuwait inflammatory bowel disease treatment market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 Inflammatory Bowel Disease Treatment Market- Competitive Analysis
9.1 Recent Developments & Impact Analysis, by Key Market Participants
9.1.1 Ansoff matrix
9.1.2 Heat map analysis
9.1.3 Major Deals and Strategic Alliances Analysis
9.1.3.1 Joint Ventures
9.1.3.2 Licensing Agreements
9.1.3.3 Product Launches
9.1.3.4 Conferences and Campaigns
9.2 Company Categorization
9.2.1 Innovators
9.2.2 Market Leaders
9.3 Vendor Landscape
9.3.1 List of key distributors and channel partners
9.3.2 Key customers
9.4 Public Companies
9.4.1 Competitive Dashboard Analysis
9.4.1.1 Market Differentiators
9.5 Private Companies
9.5.1 List of key emerging companies
9.6 Company Profiles
9.6.1 AbbVie Inc
9.6.1.1 Company overview
9.6.1.2 Financial performance
9.6.1.3 Product benchmarking
9.6.1.4 Strategic Initiatives
9.6.2 Biogen
9.6.2.1 Company overview
9.6.2.2 Financial performance
9.6.2.3 Product benchmarking
9.6.2.4 Strategic Initiatives
9.6.3 Takeda Pharmaceutical Company Limited
9.6.3.1 Company overview
9.6.3.2 Financial performance
9.6.3.3 Product benchmarking
9.6.3.4 Strategic Initiatives
9.6.4 Novartis AG
9.6.4.1 Company overview
9.6.4.2 Financial performance
9.6.4.3 Product benchmarking
9.6.4.4 Strategic Initiatives
9.6.5 Pfizer Inc
9.6.5.1 Company overview
9.6.5.2 Financial performance
9.6.5.3 Product benchmarking
9.6.5.4 Strategic Initiatives
9.6.6 Lilly
9.6.6.1 Company overview
9.6.6.2 Financial performance
9.6.6.3 Product benchmarking
9.6.6.4 Strategic Initiatives
9.6.7 UCB S.A.
9.6.7.1 Company overview
9.6.7.2 Financial performance
9.6.7.3 Product benchmarking
9.6.7.4 Strategic initiatives
9.6.8 Johnson & Johnson Services, Inc.
9.6.8.1 Company overview
9.6.8.2 Financial performance
9.6.8.3 Product benchmarking
9.6.8.4 Strategic initiatives
9.6.9 CELLTRION INC
9.6.9.1 Company overview
9.6.9.2 Financial performance
9.6.9.3 Product benchmarking
9.6.9.4 Strategic initiatives
9.6.10 Merck & Co., Inc
9.6.10.1 Company overview
9.6.10.2 Financial performance
9.6.10.3 Product benchmarking
9.6.10.4 Strategic initiatives

List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Inflammatory Bowel Disease Treatment Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 6 Global Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 7 Global Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 8 Global Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 9 North America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 10 North America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 11 North America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 12 North America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 13 North America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 14 U.S. Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 15 U.S. Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 16 U.S. Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 17 U.S. Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 18 Canada Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 19 Canada Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 20 Canada Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 21 Canada Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 22 Europe Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 23 Europe Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 24 Europe Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 25 Europe Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 26 Europe Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 27 Germany Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 28 Germany Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 29 Germany Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 30 Germany Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 31 UK Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 32 UK Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 33 UK Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 34 UK Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 35 France Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 36 France Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 37 France Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 38 France Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 39 Italy Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 40 Italy Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 41 Italy Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 42 Italy Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 43 Spain Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 44 Spain Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 45 Spain Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 46 Spain Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 47 Denmark Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 48 Denmark Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 49 Denmark Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 50 Denmark Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 51 Sweden Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 52 Sweden Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 53 Sweden Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 54 Sweden Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 55 Norway Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 56 Norway Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 57 Norway Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 58 Norway Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 59 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 60 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 61 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 64 Japan Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 65 Japan Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 66 Japan Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 67 Japan Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 68 China Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 69 China Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 70 China Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 71 China Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 72 India Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 73 India Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 74 India Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 75 India Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 76 South Korea Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 77 South Korea Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 78 South Korea Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 79 South Korea Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 80 Australia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 81 Australia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 82 Australia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 83 Australia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 84 Singapore Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 85 Singapore Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 86 Singapore Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 87 Singapore Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 88 Thailand Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 89 Thailand Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 90 Thailand Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Thailand Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 92 Latin America Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 93 Latin America Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 94 Latin America Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 95 Latin America Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 96 Latin America Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 97 Mexico Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 98 Mexico Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 99 Mexico Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 100 Mexico Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 101 Brazil Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 102 Brazil Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 103 Brazil Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 104 Brazil Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 105 Argentina Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 106 Argentina Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 107 Argentina Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 108 Argentina Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 109 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Country, 2018 - 2030 (USD Million)
Table 110 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 111 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 112 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 113 Middle East and Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 114 South Africa Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 115 South Africa Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 116 South Africa Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 117 South Africa Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 118 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 119 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 120 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 121 Saudi Arabia Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 122 UAE Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 123 UAE Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 124 UAE Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 125 UAE Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)
Table 126 Kuwait Inflammatory Bowel Disease Treatment Market, By Type, 2018 - 2030 (USD Million)
Table 127 Kuwait Inflammatory Bowel Disease Treatment Market, By Drug Class, 2018 - 2030 (USD Million)
Table 128 Kuwait Inflammatory Bowel Disease Treatment Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 129 Kuwait Inflammatory Bowel Disease Treatment Market, By Distribution Channel, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Inflammatory bowel disease treatment market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Inflammatory bowel disease treatment market: Type movement analysis
Fig. 17 Inflammatory bowel disease treatment market: Type segment dashboard
Fig. 18 Inflammatory bowel disease treatment market Type outlook: Key takeaways
Fig. 19 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 Crohn's disease market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 21 Inflammatory bowel disease treatment market: Drug class movement analysis
Fig. 22 Inflammatory bowel disease treatment market: Drug class segment dashboard
Fig. 23 Inflammatory bowel disease treatment market Drug class outlook: Key takeaways
Fig. 24 Aminosalicylates market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 25 Corticosteroids market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 26 TNF inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 IL inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 Anti-integrin market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 29 JAK inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 30 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Inflammatory bowel disease treatment market: Route of administration movement analysis
Fig. 32 Inflammatory bowel disease treatment market: Route of administration segment dashboard
Fig. 33 Inflammatory bowel disease treatment market Route of administration outlook: Key takeaways
Fig. 34 Oral market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Injectable market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Inflammatory bowel disease treatment market: Distribution channel movement analysis
Fig. 37 Inflammatory bowel disease treatment market: Distribution channel segment dashboard
Fig. 38 Inflammatory bowel disease treatment market Distribution channel outlook: Key takeaways
Fig. 39 Hospital pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 Retail pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 41 Online pharmacy market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 42 Regional outlook, 2022 & 2030
Fig. 43 Regional market dashboard
Fig. 44 Regional market place: Key takeaways
Fig. 45 North America, SWOT
Fig. 46 Europe, SWOT
Fig. 47 Asia Pacific, SWOT
Fig. 48 Latin America, SWOT
Fig. 49 Middle East and Africa, SWOT
Fig. 50 North America
Fig. 51 North America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 52 U.S.
Fig. 53 U.S. inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 54 Canada
Fig. 55 Canada inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 56 Europe
Fig. 57 Europe inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 58 U.K.
Fig. 59 U.K. inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 60 Germany
Fig. 61 Germany inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 62 Spain
Fig. 63 Spain inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 64 France
Fig. 65 France inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 66 Italy
Fig. 67 Italy inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 68 Denmark
Fig. 69 Denmark inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 70 Norway
Fig. 71 Norway inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 72 Sweden
Fig. 73 Sweden inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 86 Singapore
Fig. 87 Singapore inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 88 Thailand
Fig. 89 Thailand inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 90 Latin America
Fig. 91 Latin America inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 92 Brazil
Fig. 93 Brazil inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 94 Mexico
Fig. 95 Mexico inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 96 Argentina
Fig. 97 Argentina inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 98 Middle East and Africa
Fig. 99 MEA inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 100 South Africa
Fig. 101 South Africa inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 102 Saudi Arabia
Fig. 103 Saudi Arabia inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 104 UAE
Fig. 105 UAE inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 106 Kuwait
Fig. 107 Kuwait inflammatory bowel disease treatment market, 2018 - 2030 (USD Million)
Fig. 108 Ansoff Matrix
Fig. 109 Heat map analysis
Fig. 110 Market differentiators

Companies Mentioned

  • AbbVie Inc
  • Biogen
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Pfizer Inc
  • Lilly
  • UCB S.A.
  • Johnson & Johnson Services, Inc.
  • CELLTRION INC
  • Merck & Co., Inc

Methodology

Loading
LOADING...